Francis Crick Institute

The Francis Crick Institute is one of Europe’s leading biomedical research institutes, dedicated to understanding the fundamental biology behind human health and disease. Founded in 2015 and headquartered in London, United Kingdom, the institute was created through a partnership between leading UK research organizations including Cancer Research UK, Medical Research Council, Wellcome, University College London, Imperial College London, and King’s College London.

The institute conducts world-class research across a wide range of biomedical fields, including cancer biology, immunology, infectious diseases, neuroscience, genetics, stem cell biology, and molecular medicine. Its scientists work to uncover the biological mechanisms that cause diseases and translate discoveries into new approaches for prevention, diagnosis, and treatment.

The Francis Crick Institute operates advanced research facilities equipped with cutting-edge technologies in imaging, genomics, bioinformatics, and molecular biology. It encourages collaboration between scientists from different disciplines to accelerate innovation in healthcare research.

The institute works closely with universities, hospitals, biotechnology companies, pharmaceutical organizations, and global research networks. Its research programs contribute to understanding disease pathways, identifying potential therapeutic targets, and supporting future drug discovery.

The organization maintains high standards of scientific excellence, research ethics, laboratory safety, and responsible data management.

Named after Nobel Prize-winning scientist Francis Crick, the institute represents one of the UK’s most ambitious biomedical research initiatives. Through interdisciplinary research and international collaboration, the Francis Crick Institute continues to advance discoveries that could transform healthcare and improve patient outcomes worldwide.